Evidence map›Paper›PMID 34807908›Full record

ArticlePloS one2021

The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic.

Lori A Brotto, Kyle Chankasingh, Alexandra Baaske, Arianne Albert, Amy Booth, Angela Kaida, Laurie W Smith, Sarai Racey, Anna Gottschlich, Melanie C M Murray and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lori A BrottoDepartment of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.ORCID 0000-0001-7552-8588
Kyle ChankasinghFaculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Alexandra BaaskeWomen's Health Research Institute, Vancouver, Canada.
Arianne AlbertWomen's Health Research Institute, Vancouver, Canada.ORCID 0000-0002-3050-0888
Amy BoothWomen's Health Research Institute, Vancouver, Canada.
Angela KaidaWomen's Health Research Institute, Vancouver, Canada.ORCID 0000-0003-0329-1926
Laurie W SmithWomen's Health Research Institute, Vancouver, Canada.ORCID 0000-0002-9463-1713
Sarai RaceyWomen's Health Research Institute, Vancouver, Canada.
Anna GottschlichWomen's Health Research Institute, Vancouver, Canada.
Melanie C M MurrayDepartment of Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
Manish SadaranganiDepartment of Pediatrics, University of British Columbia, Vancouver, Canada.
Gina S OgilvieWomen's Health Research Institute, Vancouver, Canada.
Liisa GaleaWomen's Health Research Institute, Vancouver, Canada.
Women's Health Research Institute · CAUniversity of British Columbia · CASimon Fraser University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe SARS-CoV-2 (COVID-19) pandemic has had profound physical and mental health effects on populations around the world. Limited empirical research has used a gender-based lens to evaluate the mental health impacts of the pandemic, overlooking the impact of public health measures on marginalized groups, such as women, and the gender diverse community. This study used a gender-based analysis to determine the prevalence of psychosocial symptoms and substance use (alcohol and cannabis use in particular) by age, ethnicity, income, rurality, education level, Indigenous status, and sexual orientation.

methodsParticipants in the study were recruited from previously established cohorts as a part of the COVID-19 Rapid Evidence Study of a Provincial Population-Based Cohort for Gender and Sex (RESPPONSE) study. Those who agreed to participate were asked to self-report symptoms of depression, anxiety, pandemic stress, loneliness, alcohol use, and cannabis use across five phases of the pandemic as well as retrospectively before the pandemic.

resultsFor all psychosocial outcomes, there was a significant effect of time with all five phases of the pandemic being associated with more symptoms of depression, anxiety, stress, and loneliness relative to pre-COVID levels (p < .0001). Gender was significantly associated with all outcomes (p < .0001) with men exhibiting lower scores (i.e., fewer symptoms) than women and gender diverse participants, and women exhibiting lower scores than the gender diverse group. Other significant predictors were age (younger populations experiencing more symptoms, p < .0001), ethnicity (Chinese/Taiwanese individuals experiencing fewer symptoms, p = .005), and Indigenous status (Indigenous individuals experiencing more symptoms, p < .0001). Alcohol use and cannabis use increased relative to pre-pandemic levels, and women reported a greater increase in cannabis use than men (p < .0001).

conclusionsOur findings highlight the need for policy makers and leaders to prioritize women, gender-diverse individuals, and young people when tailoring public health measures for future pandemics.

Indexed as

AdultAgedAge FactorsAlcohol DrinkingCOVID-19FemaleHumansMaleMarijuana AbuseMental HealthMiddle AgedRace FactorsSex FactorsSocioeconomic Factors

Identifiers

PMID34807908
PMCPMC8608308
OpenAlexW3216421396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.